Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATRA | FIMM | pan-cancer | AAC | 0.069 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |